How the US FDA MIDD paired pilot program helps sponsors Blog 美国 FDA MIDD 配对试点计划如何帮助赞助商 2025 年 2 月 28 日 For the past couple of decades, leading American institutions, pharmaceutical and biotechnology…Certara2025 年 2 月 28 日
Measuring metabolites in index clinical DDI studies Blog 揭秘临床 DDI 研究:精准测量代谢产物 2025 年 2 月 7 日A key drug development safety consideration is whether the drug candidate will interact…Certara2025 年 2 月 7 日
Key development considerations for cell therapies Blog 细胞疗法开发的主要考虑因素 2024 年 12 月 5 日 What is a “cell therapy”? Nearly every recent oncology clinical conference has…Certara2024 年 12 月 5 日
PBPK modeling to support bioequivalence & generic product approvals Blog 支持生物等效性和仿制药审批的 PBPK 建模 Physiologically-based pharmacokinetic modeling can be used to support bioequivalence (BE) assessment of complex and locally…Certara2024 年 11 月 12 日
The future is now: Virtual clinical trials transforming drug development Blog The future is now: Virtual clinical trials transforming drug development Welcome to the forefront of drug development innovation! The drug development landscape is rapidly evolving,…Certara2024 年 6 月 4 日
Phoenix UGM 2024: A day of innovation and collaboration Blog Phoenix UGM 2024: A day of innovation and collaboration The Phoenix UGM featured industry expert insights, peer networking, and glimpses into the latest PK/PD…Certara2024 年 5 月 31 日